Lynn Miesel - Concepedia

Author

Lynn Miesel

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

L Miesel, L. Miesel, Lynn Miesel

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy WuXi AppTec (China)University of Utah Cidara Therapeutics (United States)

About

Lynn Miesel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, microbiology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	580
2	Natural Sciences	8	8	215
3	Biochemistry	7	7	220
4	Health Sciences	3	3	219
5	Cell Biology	1	1	50

Lynn Miesel

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
NADH Dehydrogenase Defects Confer Isoniazid Resistance and Conditional Lethality in <i>Mycobacterium smegmatis</i> Lynn Miesel, Torin R. Weisbrod, Jovita Marcinkeviciene, Journal of Bacteriology	1998	153
Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus Joann Huber, Robert G. K. Donald, Sang Ho Lee, Chemistry & Biology Methicillin-resistant Staphylococcus AureusHealth SciencesAntimicrobial SusceptibilityMedicineAntibiotic Adjuvant	2009	112
Broadening the Spectrum of β-Lactam Antibiotics through Inhibition of Signal Peptidase Type I Alex G. Therien, Joann Huber, Kenneth E. Wilson, Antimicrobial Agents and Chemotherapy Spsb InhibitorsAntimicrobial ChemotherapyBacterial PathogensDrug ResistanceAntibacterial Mechanisms	2012	77
Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents Sheo B. Singh, David E. Kaelin, Jin Wu, ACS Medicinal Chemistry Letters Antimicrobial ChemotherapyDrug ResistanceAm8191 BoundAntimicrobial TherapyAntibacterial Mechanisms	2014	75
Potent LpxC Inhibitors with <i>In Vitro</i> Activity against Multidrug-Resistant Pseudomonas aeruginosa Kevin M. Krause, Cat M. Haglund, Christy M. Hebner, Antimicrobial Agents and Chemotherapy	2019	59
Structure of the Bacterial Deacetylase LpxC Bound to the Nucleotide Reaction Product Reveals Mechanisms of Oxyanion Stabilization and Proton Transfer Gina M. Clayton, Daniel J. Klein, Keith Rickert, Journal of Biological Chemistry	2013	51
Evidence that SbcB and RecF pathway functions contribute to RecBCD-dependent transductional recombination Lynn Miesel, J R Roth Journal of Bacteriology Reverse GeneticsGeneticsMolecular BiologyMolecular GeneticsTranscriptional Regulation	1996	50
Screening for Antibacterial Inhibitors of the UDP-3-O-(R-3-Hydroxymyristoyl)-N-Acetylglucosamine Deacetylase (LpxC) Using a High-Throughput Mass Spectrometry Assay Erik F. Langsdorf, Asra Malikzay, William A. LaMarr, SLAS DISCOVERY Bioorganic ChemistryEscherichia ColiAntimicrobial ChemotherapyPharmaceutical ChemistryDrug Resistance	2009	50
Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy Lynn Miesel, Kun‐Yuan Lin, Voon Ong Pharmacology Research & Perspectives	2019	43
Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2) Sheo B. Singh, David E. Kaelin, Jin Wu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntimicrobial Drug DiscoveryMedicineAntibiotic AdjuvantBroad-spectrum Antibacterial Agents-sar	2015	40

Page 1